<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="- including this research content - immediately available in PubMed" exact="Central" post="and other publicly funded repositories, such as the WHO"/>
 <result pre="proteins to host angiotensin-converting enzyme 2 (ACE2). Following entry, the" exact="viral" post="RNA is released in the cytoplasm - a potential"/>
 <result pre="synthesizes mediate both replication and transcription. The Zn2+ can stop" exact="viral" post="replication by inactivating (â€•|) RdRP. Another bioactive component of"/>
 <result pre="produced through discontinuous transcription which are eventually translated to synthesize" exact="viral" post="proteins. Generally, viral nucleocapsids are assembled from genomic RNA"/>
 <result pre="transcription which are eventually translated to synthesize viral proteins. Generally," exact="viral" post="nucleocapsids are assembled from genomic RNA and N protein"/>
 <result pre="followed by budding into the lumen of the endoplasmic reticulumâ€&quot;Golgi" exact="intermediate" post="compartment. Virions are then released from the infected cell"/>
 <result pre="last few decades, two major groups of CoVs namely severe" exact="acute" post="respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome"/>
 <result pre="few decades, two major groups of CoVs namely severe acute" exact="respiratory" post="syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus"/>
 <result pre="decades, two major groups of CoVs namely severe acute respiratory" exact="syndrome" post="coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV)"/>
 <result pre="namely severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East" exact="respiratory" post="syndrome coronavirus (MERS-CoV) have caused epidemics with high mortality"/>
 <result pre="severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory" exact="syndrome" post="coronavirus (MERS-CoV) have caused epidemics with high mortality (Hui"/>
 <result pre="family - SARS-CoV-2 is responsible for the ongoing pandemic Coronavirus" exact="Disease" post="2019 (COVID-19). On March 11, 2020, World Health Organization"/>
 <result pre="of alveolar cells (also known as pneumocytes) and alveolar macrophages." exact="Infection" post="by the SARS-CoV-2 augments inflammatory conditions in the lungs,"/>
 <result pre="by the SARS-CoV-2 augments inflammatory conditions in the lungs, causing" exact="pneumonia" post="with symptoms like dry cough, chest pain, fever, and"/>
 <result pre="in the lungs, causing pneumonia with symptoms like dry cough," exact="chest" post="pain, fever, and difficulty in breathing (Huang et al.,"/>
 <result pre="et al., 2020). Notably, ACE2 is widely expressed on the" exact="epithelial" post="cells of alveoli, trachea, bronchi, bronchial serous glands (Liu"/>
 <result pre="expressed on the epithelial cells of alveoli, trachea, bronchi, bronchial" exact="serous" post="glands (Liu et al., 2011), and alveolar monocytes and"/>
 <result pre="and macrophages (Kuba et al., 2005). The fusion of the" exact="viral" post="E proteins and endosomal phospholipidic membrane allows the release"/>
 <result pre="proteins and endosomal phospholipidic membrane allows the release of the" exact="viral" post="+ RNA into the host cell cytoplasm. Central to"/>
 <result pre="of the viral + RNA into the host cell cytoplasm." exact="Central" post="to its replication, SARS-CoV-2 uses its own genome-encoded RNA-dependent"/>
 <result pre="polymerase (RdRp). The RdRp which is integrated into a membrane-associated" exact="viral" post="enzyme complex synthesizes the negative-strand RNA (âˆ’RNA) using the"/>
 <result pre="RNA strand is then used as a template to synthesize" exact="viral" post="mRNAs. The polycistronic ribosome machinery of the infected cell"/>
 <result pre="cells to finally enter into the Golgi compartment. Consequently, the" exact="viral" post="genomic RNA is packaged into the nucleocapsid and then"/>
 <result pre="articles (Devaux et al., 2020; Fehr and Perlman, 2015). 3" exact="Immunological" post="profile of COVID-19 patients Changes in the immunological profile"/>
 <result pre="words, the CD4+ and CD8+ T cell responses to a" exact="viral infection" post="require distinct costimulatory pathways for activation that in turn"/>
 <result pre="the CD4+ and CD8+ T cell responses to a viral" exact="infection" post="require distinct costimulatory pathways for activation that in turn"/>
 <result pre="by the cells by limiting duration and severity of the" exact="disease" post="(Jansen et al., 2019). An increased concentration of C-reactive"/>
 <result pre="Zn level ranges between 10â€&quot;18 mol/L representing 0.1 % of" exact="total" post="body Zn (Foster and Samman, 2012). Earlier it was"/>
 <result pre="(Huang et al., 2005). 5 Zinc boosts immune responses during" exact="viral infection" post="Zn is involved in a number of immunome activation"/>
 <result pre="et al., 2005). 5 Zinc boosts immune responses during viral" exact="infection" post="Zn is involved in a number of immunome activation"/>
 <result pre="cytokines (such as IL-1b, IL-6, IL-8, TNF-Î±, and MCP-1), chemokines," exact="acute" post="phase proteins (CRP and fibrinogen), matrix metalloproteinases, adhesion molecules,"/>
 <result pre="essential in extravasation of neutrophils to the site of the" exact="infection" post="to uptake and kill the infectious microorganisms (Hasan et"/>
 <result pre="the site of the infection to uptake and kill the" exact="infectious" post="microorganisms (Hasan et al., 2016). For more detailed functions"/>
 <result pre="are important in eliciting immune response in the state of" exact="infections" post="(Maywald and Rink, 2017; Rosenkranz et al., 2016). In"/>
 <result pre="the Zn, the same element also acts directly on the" exact="infectious" post="pathogens more specifically for a number of viruses. In"/>
 <result pre="number of viruses including influenza virus (Uchide et al., 2002)," exact="respiratory" post="syncytial virus (Suara and Crowe, 2004), and several picornaviruses"/>
 <result pre="2009). Replication of other viruses such as HIV, HSV, and" exact="vaccinia" post="virus as well as SARS-CoVs were also known to"/>
 <result pre="salts. In those viruses, Zn is known to inhibit the" exact="viral" post="entry, blocking of polyprotein processing, or inhibition of viral"/>
 <result pre="the viral entry, blocking of polyprotein processing, or inhibition of" exact="viral" post="RdRp activity (Haraguchi et al., 1999; Katz and Margalith,"/>
 <result pre="of treatment strategies which have been used to treat other" exact="viral" post="infections such as: (i) convalescent plasma (Casadevall and Pirofski,"/>
 <result pre="treatment strategies which have been used to treat other viral" exact="infections" post="such as: (i) convalescent plasma (Casadevall and Pirofski, 2020;"/>
 <result pre="a combination of protease inhibitors that are used to treat" exact="HIV infection," post="(iv) Remdesivir, a nucleotide analogue that inhibits RNA polymerase"/>
 <result pre="(v) azithromycin and doxycycline - commonly used antibiotics to inhibit" exact="viral" post="replication and IL-6 production (Sargiacomo et al., 2020), (vi)"/>
 <result pre="via maternal milk was shown to successfully treat lethal HCoV-OC43" exact="infection" post="in newborn C57BL/6 mice (Keyaerts et al., 2009). Chloroquine"/>
 <result pre="hydroxychloroquine were suggested to treat COVID-19 patients with or without" exact="diabetes" post="(Singh et al., 2020). Fig. 1 Structure of chloroquine"/>
 <result pre="of black seeds and its oil has been recommended for" exact="rheumatoid arthritis," post="asthma, inflammatory diseases, diabetes and digestive diseases (Ahmad et"/>
 <result pre="oil has been recommended for rheumatoid arthritis, asthma, inflammatory diseases," exact="diabetes" post="and digestive diseases (Ahmad et al., 2013; Butt and"/>
 <result pre="Î¼1- and Îº-opioid receptor subtypes (Abdel-Fattah et al., 2000). Furthermore," exact="brain" post="endogenous angiotensin II was suggested to be involved in"/>
 <result pre="that Zn is involved in boosting the immune response against" exact="viral infection" post="including SARS-CoV-2. Immune-boosting activities of Zn include proliferation and"/>
 <result pre="Zn is involved in boosting the immune response against viral" exact="infection" post="including SARS-CoV-2. Immune-boosting activities of Zn include proliferation and"/>
 <result pre="to SARS-CoV-2 infected pneumocytes is crucial to fight back the" exact="viral" post="pathogenesis. However, oral supplement of Zn alone may not"/>
 <result pre="SARS-CoV-2 as well as inhibit its replication by blocking the" exact="viral" post="RdRp. However, it is important to identify the right"/>
 <result pre="mg). Individuals with health conditions such as with liver and" exact="kidney diseases" post="as well as pregnant women must consult the physicians"/>
 <result pre="and clinical characteristics of 99 cases of 2019 novel coronavirus" exact="pneumonia" post="in Wuhan, China: a descriptive studyLancet (London, England)395202050751310.1016/S0140-6736(20)30211-7 ColsonP.RolainJ.-M.LagierJ.-C.BrouquiP.RaoultD.Chloroquine"/>
 <result pre="ContiP.GallengaC.E.TeteG.CaraffaA.RonconiG.YounesA.ToniatoE.RossR.KritasS.K.How to reduce the likelihood of coronavirus-19 (CoV-19 or SARS-CoV-2)" exact="infection" post="and lung inflammation mediated by IL-1J. Biol. Regul. Homeost."/>
 <result pre="reduce the likelihood of coronavirus-19 (CoV-19 or SARS-CoV-2) infection and" exact="lung inflammation" post="mediated by IL-1J. Biol. Regul. Homeost. Agents202010.23812/Editorial-Conti-2 CortegianiA.IngogliaG.IppolitoM.GiarratanoA.EinavS.A systematic"/>
 <result pre="trafficking, and signalsJ. Biol. Chem.2812006240852408910.1074/jbc.R60001120016793761 DenisonM.R.PerlmanS.Translation and processing of mouse" exact="hepatitis" post="virus virion RNA in a cell-free systemJ. Virol.60198612183018279 DenisonM.R.ZoltickP.W.HughesS.A.GiangrecoB.OlsonA.L.PerlmanS.LeibowitzJ.L.WeissS.R.Intracellular"/>
 <result pre="FurutaY.TakahashiK.ShirakiK.SakamotoK.SmeeD.F.BarnardD.L.GowenB.B.JulanderJ.G.MorreyJ.D.T-705 (favipiravir) and related compounds: novel broad-spectrum inhibitors of RNA" exact="viral" post="infectionsAntiviral Res.8220099510210.1016/j.antiviral.2009.02.19819428599 GaoJ.TianZ.YangX.Breakthrough: chloroquine phosphate has shown apparent efficacy"/>
 <result pre="phosphate has shown apparent efficacy in treatment of COVID-19 associated" exact="pneumonia" post="in clinical studiesBiosci. Trends142020727310.5582/bst.2020.0104732074550 GholamnezhadZ.HavakhahS.BoskabadyM.H.Preclinical and clinical effects of"/>
 <result pre="compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East" exact="respiratory" post="syndrome coronavirusJ. Biol. Chem.202010.1074/jbc.AC120.013056 HammingI.TimensW.BulthuisM.L.C.LelyA.T.NavisG.J.van GoorH.Tissue distribution of ACE2"/>
 <result pre="remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory" exact="syndrome" post="coronavirusJ. Biol. Chem.202010.1074/jbc.AC120.013056 HammingI.TimensW.BulthuisM.L.C.LelyA.T.NavisG.J.van GoorH.Tissue distribution of ACE2 protein,"/>
 <result pre="first step in understanding SARS pathogenesisJ. Pathol.203200463163710.1002/path.157015141377 HaraguchiY.SakuraiH.HussainS.AnnerB.M.HoshinoH.Inhibition of HIV-1" exact="infection" post="by zinc group metal compoundsAntiviral Res.43199912313310.1016/s0166-3542(99)00040-610517314 HasanR.RinkL.HaaseH.Chelation of free"/>
 <result pre="with 2019 novel coronavirus in Wuhan, ChinaLancet (London, England)395202049750610.1016/S0140-6736(20)30183-5 HuiD.S.MemishZ.A.ZumlaA.Severe" exact="acute" post="respiratory syndrome vs. the Middle East respiratory syndromeCurr. Opin."/>
 <result pre="2019 novel coronavirus in Wuhan, ChinaLancet (London, England)395202049750610.1016/S0140-6736(20)30183-5 HuiD.S.MemishZ.A.ZumlaA.Severe acute" exact="respiratory" post="syndrome vs. the Middle East respiratory syndromeCurr. Opin. Pulm."/>
 <result pre="novel coronavirus in Wuhan, ChinaLancet (London, England)395202049750610.1016/S0140-6736(20)30183-5 HuiD.S.MemishZ.A.ZumlaA.Severe acute respiratory" exact="syndrome" post="vs. the Middle East respiratory syndromeCurr. Opin. Pulm. Med.20201423324110.1097/MCP.000000000000004624626235"/>
 <result pre="(London, England)395202049750610.1016/S0140-6736(20)30183-5 HuiD.S.MemishZ.A.ZumlaA.Severe acute respiratory syndrome vs. the Middle East" exact="respiratory" post="syndromeCurr. Opin. Pulm. Med.20201423324110.1097/MCP.000000000000004624626235 IjazH.TulainU.R.QureshiJ.DanishZ.MusayabS.AkhtarM.F.SaleemA.KhanK.K.ZamanM.WaheedI.KhanI.Abdel-DaimM.Review: nigella sativa (Prophetic medicine):"/>
 <result pre="JansenJ.M.GerlachT.ElbaheshH.RimmelzwaanG.F.SalettiG.Influenza virus-specific CD4+ and CD8+ T cell-mediated immunity induced by" exact="infection" post="and vaccinationJ. Clin. Virol.1192019445210.1016/j.jcv.2019.08.00931491709 JiangP.MizushimaN.Autophagy and human diseasesCell Res.242014697910.1038/cr.2013.16124323045"/>
 <result pre="vaccinationJ. Clin. Virol.1192019445210.1016/j.jcv.2019.08.00931491709 JiangP.MizushimaN.Autophagy and human diseasesCell Res.242014697910.1038/cr.2013.16124323045 KatzE.MargalithE.Inhibition of" exact="vaccinia" post="virus maturation by zinc chlorideAntimicrob. Agents Chemother.19198121321710.1128/aac.19.2.2137347557 KaushikN.SubramaniC.AnangS.MuthumohanR.ShalimarNayakB.Ranjith-KumarC.T.SurjitM.Zinc salts"/>
 <result pre="virus maturation by zinc chlorideAntimicrob. Agents Chemother.19198121321710.1128/aac.19.2.2137347557 KaushikN.SubramaniC.AnangS.MuthumohanR.ShalimarNayakB.Ranjith-KumarC.T.SurjitM.Zinc salts block" exact="hepatitis" post="e virus replication by inhibiting the activity of viral"/>
 <result pre="block hepatitis e virus replication by inhibiting the activity of" exact="viral" post="RNA-dependent RNA polymeraseJ. Virol.20179110.1128/JVI.00754-17 KeyaertsE.LiS.VijgenL.RysmanE.VerbeeckJ.Van RanstM.MaesP.Antiviral activity of chloroquine"/>
 <result pre="Virol.20179110.1128/JVI.00754-17 KeyaertsE.LiS.VijgenL.RysmanE.VerbeeckJ.Van RanstM.MaesP.Antiviral activity of chloroquine against human coronavirus OC43" exact="infection" post="in newborn miceAntimicrob. Agents Chemother.5320093416342110.1128/AAC.01509-0819506054 KiralanM.Volatile compounds of black"/>
 <result pre="case seriesLancet Infect. Dis.202010.1016/S1473-3099(20)30200-0 LevineB.KroemerG.Biological functions of autophagy genes: a" exact="disease" post="perspectiveCell1762019114210.1016/j.cell.2018.09.04830633901 LiW.MooreM.J.VasilievaN.SuiJ.WongS.K.BerneM.A.SomasundaranM.SullivanJ.L.LuzuriagaK.GreenoughT.C.ChoeH.FarzanM.Angiotensin-converting enzyme 2 is a functional receptor for"/>
 <result pre="transporters: nutritional and physiologic regulationAnnu. Rev. Nutr.29200915317610.1146/annurev-nutr-033009-08331219400752 LiuL.WeiQ.AlvarezX.WangH.DuY.ZhuH.JiangH.ZhouJ.LamP.ZhangL.LacknerA.QinC.ChenZ.Epithelial cells lining" exact="salivary gland" post="ducts are early target cells of severe acute respiratory"/>
 <result pre="lining salivary gland ducts are early target cells of severe" exact="acute" post="respiratory syndrome coronavirus infection in the upper respiratory tracts"/>
 <result pre="salivary gland ducts are early target cells of severe acute" exact="respiratory" post="syndrome coronavirus infection in the upper respiratory tracts of"/>
 <result pre="gland ducts are early target cells of severe acute respiratory" exact="syndrome" post="coronavirus infection in the upper respiratory tracts of rhesus"/>
 <result pre="are early target cells of severe acute respiratory syndrome coronavirus" exact="infection" post="in the upper respiratory tracts of rhesus macaquesJ. Virol.8520114025403010.1128/JVI.02292-1021289121"/>
 <result pre="cells of severe acute respiratory syndrome coronavirus infection in the" exact="upper" post="respiratory tracts of rhesus macaquesJ. Virol.8520114025403010.1128/JVI.02292-1021289121 LiuX.El-AtyAbdA.MChoS.-KYangAParkJ.-HShimJ.-HCharacterization of secondary"/>
 <result pre="of severe acute respiratory syndrome coronavirus infection in the upper" exact="respiratory" post="tracts of rhesus macaquesJ. Virol.8520114025403010.1128/JVI.02292-1021289121 LiuX.El-AtyAbdA.MChoS.-KYangAParkJ.-HShimJ.-HCharacterization of secondary volatile"/>
 <result pre="the upper respiratory tracts of rhesus macaquesJ. Virol.8520114025403010.1128/JVI.02292-1021289121 LiuX.El-AtyAbdA.MChoS.-KYangAParkJ.-HShimJ.-HCharacterization of" exact="secondary" post="volatile profiles in Nigella sativa seeds from two different"/>
 <result pre="and pathogenesis of coronavirusesTrends Microbiol.24201649050210.1016/j.tim.2016.03.00327012512 SuaraR.O.CroweJ.E.J.Effect of zinc salts on" exact="respiratory" post="syncytial virus replicationAntimicrob. Agents Chemother.48200478379010.1128/aac.48.3.783-790.200414982765 TakaiS.SongK.TanakaT.OkunishiH.MiyazakiM.Antinociceptive effects of angiotensin-converting"/>
 <result pre="antioxidants on apoptosis induced by influenza virus infection: inhibition of" exact="viral" post="gene replication and transcription with pyrrolidine dithiocarbamateAntiviral Res.56200220721710.1016/s0166-3542(02)00109-212406505 ValleeB.L.FalchukK.H.The"/>
 <result pre="dithiocarbamateAntiviral Res.56200220721710.1016/s0166-3542(02)00109-212406505 ValleeB.L.FalchukK.H.The biochemical basis of zinc physiologyPhysiol. Rev.731993791188419966 WangL.HeW.YuX.HuD.BaoM.LiuH.ZhouJ.JiangH.Coronavirus" exact="disease" post="2019 in elderly patients: characteristics and prognostic factors based"/>
 <result pre="in vitroCell Res.202010.1038/s41422-020-0282-0 WangZ.YangB.LiQ.WenL.ZhangR.Clinical features of 69 cases with coronavirus" exact="disease" post="2019 in Wuhan, ChinaClin. Infect. Dis. Off. Publ. Infect."/>
 <result pre="Opin. Immunol.12200044845510.1016/s0952-7915(00)00119-910899032 WongH.K.LeeC.K.Pivotal role of convalescent plasma in managing emerging" exact="infectious" post="diseasesVox Sang.202010.1111/vox.12927 WuA.PengY.HuangB.DingX.WangX.NiuP.MengJ.ZhuZ.ZhangZ.WangJ.ShengJ.QuanL.XiaZ.TanW.ChengG.JiangT.Genome composition and divergence of the novel"/>
 <result pre="optimized dosing design of hydroxychloroquine for the treatment of severe" exact="acute" post="respiratory syndrome coronavirus 2 (SARS-CoV-2)Clin. Infect. Dis. an Off."/>
 <result pre="dosing design of hydroxychloroquine for the treatment of severe acute" exact="respiratory" post="syndrome coronavirus 2 (SARS-CoV-2)Clin. Infect. Dis. an Off. Publ."/>
 <result pre="design of hydroxychloroquine for the treatment of severe acute respiratory" exact="syndrome" post="coronavirus 2 (SARS-CoV-2)Clin. Infect. Dis. an Off. Publ. Infect."/>
 <result pre="Infect. Dis. Soc. Am.202010.1093/cid/ciaa237 ZhuN.ZhangD.WangW.LiX.YangB.SongJ.ZhaoX.HuangB.ShiW.LuR.NiuP.ZhanF.MaX.WangD.XuW.WuG.GaoG.F.TanW.A novel coronavirus from patients with" exact="pneumonia" post="in China, 2019N. Engl. J. Med.382202072773310.1056/NEJMoa200101731978945"/>
</results>
